Sandy Cove Advisors’s Medtronic MDT Stock Holding History

Sandy Cove Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-391	Closed	-$43K	–	262
2022 Q1	$43K	Hold	391	–	–	0.04%	218
2021 Q4	$40K	Buy	+391	New	+$45.3K	0.03%	216

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sandy Cove Advisors's MDT Position: Q2 2022 in Review

Sandy Cove Advisors sold out of Medtronic (MDT) in Q2 2022, closing a stake of 391 shares — an estimated $43K sold.

Sandy Cove Advisors first reported a position in MDT in Q4 2021 and held it in 2 quarters. The position peaked at $43K in Q1 2022. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

Sandy Cove Advisors reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
Sandy Cove Advisors sold 391 Medtronic shares in Q2 2022, an estimated $43K.
Sandy Cove Advisors first reported a position in Medtronic in Q4 2021 and held it in 2 quarters.
Sandy Cove Advisors's Medtronic position peaked at $43K in Q1 2022.
2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Sandy Cove Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.